Tiffany Thorn
Gründer bei BIVICTRIX THERAPEUTICS PLC
Vermögen: 235 080 $ am 30.04.2024
Aktive Positionen von Tiffany Thorn
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| BIVICTRIX THERAPEUTICS PLC | Direktor/Vorstandsmitglied | 01.01.2016 | - |
| Vorstandsvorsitzender | 01.01.2016 | - | |
| Gründer | 01.01.2016 | - |
Karriereverlauf von Tiffany Thorn
Ehemalige bekannte Positionen von Tiffany Thorn
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| MOTIF BIO PLC | Direktor/Vorstandsmitglied | 14.06.2021 | - |
| Vorstandsvorsitzender | 14.06.2021 | - |
Ausbildung von Tiffany Thorn
| The University of Manchester | Graduate Degree |
| University of Lancaster | Undergraduate Degree |
Statistik
International
| Vereinigtes Königreich | 5 |
Operativ
| Director/Board Member | 2 |
| Chief Executive Officer | 2 |
| Founder | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| BIVICTRIX THERAPEUTICS PLC | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Motif Bio Plc
 Motif Bio Plc Pharmaceuticals: MajorHealth Technology Motif Bio Plc is a clinical stage biopharmaceutical company, which engages in the development and commercialization of pharmaceutical formulations. The company focuses on developing novel antibiotics designed to be effective against serious and life-threatening infections caused by multi-drug resistant bacteria. It offers Iclaprim, a novel diaminopyrimidine antibiotic that inhibits an essential bacterial enzyme called dihydrofolate reductase. The company was founded by Jonathan E. Gold on November 20, 2014 and is headquartered in Princeton, NJ. | Health Technology |
- Börse
- Insiders
- Tiffany Thorn
- Erfahrung
